Patients addicted to prescription opioids (POs) who are taking buprenorphine (a medication used in opioid addiction treatment) may respond better to tapering of the drug over four weeks than over shorter periods when the taper is followed by naltrexone (a medication that blocks opioid strength), according to a clinical trial report by Stacey C. Sigmon, Ph.D., of the University of Vermont, Burlington, and colleagues.
- The Action List
- Clinical Trial Evaluates Outpatient Detoxification in Prescription Opioid Abusers
Clinical Trial Evaluates Outpatient Detoxification in Prescription Opioid Abusers
27 Oct 2013
DISCLAIMER: Bankix Systems Ltd is the registered name of a Canadian firm since 2003, and bankixsystems.com is its OFFICIAL website. Besides these entities, we have no relationship with anyone, business, website, or any other entity anywhere in the world, claiming to be Bankix Systems, or using a similar name, and creating the impression that it has some connection with our company. We do not endorse and are therefore, not responsible for any act or lack thereof by any such entity. Bankix Systems Ltd is also not responsible for the content of the description of products and services linked to our site nor does it necessarily endorse them. The information here provided is not for diagnosing/treating your health concerns. Kindly contact your doctor or health care professional for all your healthcare requirements.
Contents © 2003-2019, BankixSystems.com. All rights reserved. Unauthorized reproduction strictly prohibited. Information based on best available resources. Opinions are current and subject to change.